ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,321.41
0.00%
Dow Jones
39,872.99
0.00%
US Dollar vs MXN
16.66955
0.29%
Brent Oil
82.095
-0.42%
Bitcoin
69,810.01
-0.46%
Registration Strip Icon for discussion Regístrate para interactuar en nuestros foros activos para discutir con inversores de ideas afines.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Sarepta Therapeutics, Inc. (MM) (AVII)

  7. Sarepta Therapeutics, Inc. (MM) (AVII) Noticias

AVII

Avi Biopharma (AVII)

Sarepta Therapeutics, Inc. (MM)
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:AVII
FechaHoraFuenteTítuloSímboloCompañía
06/05/201502:28Analyst Ratings NetworkSarepta Therapeutics Upgraded to Outperform at Robert W. Baird (AVII)NASDAQ:AVIISarepta Therapeutics, Inc. (MM)
12/07/201207:20MarketwiredBooming Biotechnology Industry Continues to Impress Investors in 2012NASDAQ:AVIISarepta Therapeutics, Inc. (MM)
12/07/201205:50MarketwiredAVI BioPharma Announces Corporate Name Change to Sarepta Therapeutics and Stock Ticker Symbol Change to "SRPT" Effective TodayNASDAQ:AVIISarepta Therapeutics, Inc. (MM)
11/07/201205:04Edgar (US Regulatory)Amended Statement of Ownership (SC 13G/A)NASDAQ:AVIISarepta Therapeutics, Inc. (MM)
06/07/201215:05MarketwiredAVI BioPharma to Present Company Overview at the Seventh Annual JMP Securities Healthcare ConferenceNASDAQ:AVIISarepta Therapeutics, Inc. (MM)
13/06/201205:03Edgar (US Regulatory)Proxy Statement (definitive) (DEF 14A)NASDAQ:AVIISarepta Therapeutics, Inc. (MM)
05/06/201215:08Edgar (US Regulatory)Current report filing (8-K)NASDAQ:AVIISarepta Therapeutics, Inc. (MM)
01/06/201216:28Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (PRE 14A)NASDAQ:AVIISarepta Therapeutics, Inc. (MM)
01/06/201215:30MarketwiredAVI BioPharma Receives NASDAQ Notice of Minimum Bid Price Non-ComplianceNASDAQ:AVIISarepta Therapeutics, Inc. (MM)
11/05/201208:59MarketwiredPotential Breakout Stock to Watch for 05/11/12: AVVC Issues News ReleaseNASDAQ:AVIISarepta Therapeutics, Inc. (MM)
10/05/201215:05MarketwiredAVI BioPharma Announces First Quarter 2012 Financial Results and Recent Corporate DevelopmentsNASDAQ:AVIISarepta Therapeutics, Inc. (MM)
10/05/201208:04Edgar (US Regulatory)Quarterly Report (10-Q)NASDAQ:AVIISarepta Therapeutics, Inc. (MM)
04/05/201207:20MarketwiredU.S Patent System to Transform From "First to Invent" to "First to File" - AVI BioPharma and XOMA Look to BenefitNASDAQ:AVIISarepta Therapeutics, Inc. (MM)
04/05/201203:14ZacksZacks #1 Rank Additions for Friday - Tale of the TapeNASDAQ:AVIISarepta Therapeutics, Inc. (MM)
03/05/201207:30MarketwiredAVI BioPharma Announces First Quarter 2012 Financial Results and Corporate Update Conference CallNASDAQ:AVIISarepta Therapeutics, Inc. (MM)
02/05/201203:14ZacksZacks #1 Rank Additions for Wednesday - Tale of the TapeNASDAQ:AVIISarepta Therapeutics, Inc. (MM)
30/04/201215:34Edgar (US Regulatory)Amended Annual Report (10-K/A)NASDAQ:AVIISarepta Therapeutics, Inc. (MM)
25/04/201216:26Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:AVIISarepta Therapeutics, Inc. (MM)
25/04/201207:30MarketwiredAVI BioPharma to Present Additional Data From the Phase IIb Study of Eteplirsen for the Treatment of Duchenne Muscular Dystro...NASDAQ:AVIISarepta Therapeutics, Inc. (MM)
20/04/201209:10Edgar (US Regulatory)Confidential Treatment Order (CT ORDER)NASDAQ:AVIISarepta Therapeutics, Inc. (MM)
02/04/201208:12Dow Jones NewsUS STOCK FUTURES: HOT STOCKS TO WATCHNASDAQ:AVIISarepta Therapeutics, Inc. (MM)
02/04/201206:00MarketwiredAVI BioPharma Announces Eteplirsen Meets Primary Endpoint, Demonstrating a Significant Increase in Dystrophin at 24 Weeks Com...NASDAQ:AVIISarepta Therapeutics, Inc. (MM)
30/03/201219:00MarketwiredAVI BioPharma Announces Conference Call and Webcast on Monday, April 2, 2012, to Discuss Top-Line Data Results From the Phase...NASDAQ:AVIISarepta Therapeutics, Inc. (MM)
30/03/201207:30MarketwiredData From AVI BioPharma's Infectious Disease Programs to Be Presented at the 22nd European Congress of Clinical Microbiology ...NASDAQ:AVIISarepta Therapeutics, Inc. (MM)
27/03/201207:30MarketwiredAVI BioPharma to Present Company Overview at the 11th Annual Needham Healthcare ConferenceNASDAQ:AVIISarepta Therapeutics, Inc. (MM)
21/03/201216:14Edgar (US Regulatory)Securities Registration Statement (simplified form) (S-3)NASDAQ:AVIISarepta Therapeutics, Inc. (MM)
13/03/201215:40Edgar (US Regulatory)Annual Report (10-K)NASDAQ:AVIISarepta Therapeutics, Inc. (MM)
12/03/201207:30MarketwiredAVI BioPharma Announces Late-Breaker Oral Presentation of Phase IIb DMD Study at 2012 AAN Annual Meeting in AprilNASDAQ:AVIISarepta Therapeutics, Inc. (MM)
01/03/201215:05MarketwiredAVI BioPharma Announces Fourth Quarter and Full Year 2011 Financial Results and Recent Corporate DevelopmentsNASDAQ:AVIISarepta Therapeutics, Inc. (MM)
28/02/201207:30MarketwiredAVI BioPharma Announces FDA Approval to Proceed With a Modified Dosing of AVI-6003 for Treatment of Marburg VirusNASDAQ:AVIISarepta Therapeutics, Inc. (MM)
 Showing the most relevant articles for your search:NASDAQ:AVII

Su Consulta Reciente

LSE
48AM
Icdps Sukuk 25
AMEX
TTAI
FCF International Qualit...
NASDAQ
GAME
GameSquare
LBNK
MSQUSDT
MSQUARE
LSE
55ZB
Investec Bnk 24
COIN
KUKYEUR
LSE
TI5G
0-5 Tips Gbp-h
UNSW3
CELLUSDT
Cellframe Token
LSE
38QI
Eurofima5.50%32
BOV
T1TW34Q
TakeTwo Interactive Soft...
COIN
MBCHUSD
TSX
ONT.SB.A
Province of Ontario
ASX
AYN
LSE
SHCA
LSE
0W9X
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados